Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 207 - Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
Patents for C07D 207 - Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom (40,304)
11/2009
11/05/2009US20090275581 Renin inhibitors
11/05/2009US20090275565 Substituted aralkyl derivatives
11/05/2009US20090275142 Compositions and methods for biodetection by nucleic acid-templated chemistry
11/05/2009US20090274656 Hepatitis c virus inhibitors
11/05/2009CA2722704A1 Cyclylamine derivatives as calcium channel blockers
11/04/2009EP2113500A1 MAPK/ERK kinase inhibitors
11/04/2009EP2112991A1 New synthons for the synthesis of chiral peptide nucleic acids and methods for preparing the same
11/04/2009EP1784388B1 Biphenyloxyacetic acid derivatives for the treatment of respiratory disease
11/04/2009EP1727804B1 N1 - ((pyrazol-1-ymethyl) -2-methylphenyl)- phatalamide derivatives and related compounds insecticides
11/04/2009EP1339684B1 Mch antagonists and their use in the treatment of obesity
11/04/2009CN101570517A 1-(4-benzyl-piperazin-1-yl)-3-phenyl-propenone derivatives
11/04/2009CN100556891C Improved method for preparing 4,4 - difluoro - proline
11/03/2009US7612216 Production of N-(methyl aryl)-2-lactam, N-(methyl cycloalkyl)-2-lactam and N-alkyl-2-lactam by reductive amination of lactones with aryl and alkyl cyano compounds
11/03/2009US7612215 No racemization during cyclization, decarbalkoxylation, decarboxylation of intermediate; separation of diastereoisomers by recrystallization; no use of toxic, expensive catalysts; Levetiracetam; treatment, prevention of hypoxic, ischemia of central nervous system
11/03/2009US7612213 (E)-ethyl 7-hydroxy-2-methyl-2-heptenate; (3E, 5E)-tert-butyl-9-(tert-butyldimethylsiloxy)-2-[(E)-ethylid ene]-4-methylnona-3,5-dienate
11/03/2009US7612103 Such as 14-O-[4-hydroxy-N-valyl-piperidin-3-yl]-sulfanylacetylmutilin
11/03/2009US7612092 Nitrogen-containing aromatic derivatives
11/03/2009US7612068 (S)-1-{2-[2-(4-Fluoro-phenylsulfanyl)-phenoxy]-ethyl}-pyrrolidine-2-carboxylic acid; glycine transport inhibitors; for schizophrenia and other psychoses
11/03/2009US7612064 Sulfopyrroles
11/03/2009US7612059 Pyrrolidine bicyclic compounds and its derivatives, compositions and methods of use
11/03/2009US7611880 Enzymatic ammonolysis process for the preparation of intermediates for DPP IV inhibitors
11/03/2009CA2457982C Use of nefiracetam for treating neurodegeneration
11/03/2009CA2442423C Therapeutic drug for psychoneurotic disorders
11/03/2009CA2420585C Amides of r-2-(aminoaryl)-propionic acids for use in the prevention of leucocyte activation
11/03/2009CA2368834C Bicyclic heteroaromatic compounds useful as lh agonists
10/2009
10/29/2009WO2009132088A1 Substituted gamma lactams as therapeutic agents
10/29/2009WO2009131669A2 Carbamate and urea inhibitors of 11beta-hydroxysteroid dehydrogenase 1
10/29/2009WO2009131196A1 Substituted pyrrolidine derivative and use thereof
10/29/2009WO2009131096A1 Compound having npy y5 receptor antagonist activity
10/29/2009WO2009131065A1 Long-chain fatty acid elongation enzyme inhibitor comprising arylsulfonyl derivative as active ingredient
10/29/2009WO2009111239A3 Pyrrolidine derivatives
10/29/2009WO2009101201A3 Mixtures of metal hydrides and ionic liquids and uses of such mixtures
10/29/2009US20090270622 Diphosphines and Metal Complexes
10/29/2009US20090270478 Ion channel modulating activity ii
10/29/2009US20090270417 Organic Compounds
10/29/2009US20090270367 Substituted hydroxyethylamine aspartyl protease inhibitors
10/29/2009US20090269855 Methods and compositions for mass spectrometry analysis
10/29/2009US20090269673 Process for the preparation of compounds containing perfluoroalkanesulfonic acid groups
10/29/2009CA2722529A1 Substituted gamma lactams as therapeutic agents
10/29/2009CA2722075A1 Long-chain fatty acyl elongase inhibitor comprising arylsulfonyl derivative as active ingredient
10/29/2009CA2721750A1 Carbamate and urea inhibitors of 11beta-hydroxysteroid dehydrogenase 1
10/29/2009CA2721576A1 Compound having npy y5 receptor antagonist activity
10/29/2009CA2720818A1 Substituted phenoxybenzamides
10/28/2009EP1811841B1 Control of parasites in animals by the use of parasiticidal 2-phenyl-3-(1h-pyrrol-2-yl) acrylonitrile derivatives
10/28/2009CN101568522A Trifluoromethoxyphenyl-substituted tetramic acid derivatives as pesticides and/or herbicides
10/28/2009CN101568260A Enantiomer-enriched alpha-,omega amino alcohol derivatives, their production and use as insect- and mite-repelling agents
10/28/2009CN101565394A Crystalline forms of atorvastatin
10/28/2009CN100554257C 1-(4-benzyl-piperazin-1-yl)-3-phenyl-propenone derivatives
10/28/2009CN100554256C Quaternary ammonium salt, electrolyte, and electrochemical device
10/28/2009CN100554251C Maleimide derivative and its preparation
10/28/2009CN100553639C Boronic acid polyvalent salts for treating thrombosis
10/27/2009US7608636 Medicines for treatment and prevention of neurogenic pain
10/27/2009US7608633 1-(4-Octylphenoxy)-3-(pyrrol-1-yl)propan-2-one, for example; for preventing and treating diseases caused by an increased activity of this enzyme, such as inflammation, pain, fever, allergies, asthma, psoriasis and endotoxic shock
10/27/2009US7608632 Sulfonamide inhibitors of aspartyl protease
10/27/2009US7608631 1-(4-{3-[2,6-Dichloro-4-(3,3-dichloro-allyloxy)-phenoxy]-propoxy}-phenyl)-1H-pyrrole, for example; protecting soybean plants against pests such as caterpillars
10/27/2009US7608617 N,N-alkylene-6-(piperidin-1-ylalkoxy)naphthalene-2-carboxamide derivatives, e.g., piperidin-1-yl-[6-(3-piperidin-1-yl-propoxy)-naphthalen-2-yl]-methanone and 3,4-dihydro-1H-isoquinolin-2-yl)-[6-(3-piperidin-1-yl-propoxy)-naphthalen-2-yl]-methanone; especially for treating obesity
10/27/2009US7608592 HCV inhibitors
10/27/2009US7608590 19-(7-Methoxy-2-phenyl-quinolin-4-yloxy)-2, 16-dioxo-3,15,17-triaza-tricyclo[15.3.0.0*4,6*]icos-7-ene-4,14-dicarboxylic acid 4-ethyl ester 14-methyl ester, for example; inhibits the NS3 protease of flavivirus such as hepatitis C virus (HCV)
10/27/2009CA2322171C Cyclic amino compounds
10/22/2009WO2009128907A1 Processes useful for the synthesis of (r)-1-{2-[4'-(3-methoxypropane-1-sulfonyl)-biphenyl-4-yl]-ethyl}-2-methyl-pyrrolidine
10/22/2009WO2009127560A1 Intermediates for the preparation of pregabalin and process for their preparation
10/22/2009WO2009094457A3 Substituted benzhydrylethers
10/22/2009WO2009072139A8 Process for producing 2-[1-methyl-5-(4-methylbenzoyl)- pyrrol-2- yl]acetic acid or salt thereof
10/22/2009WO2009057137A4 A process for the purification of levetiracetam
10/22/2009US20090264650 Prophylactic/Therapeutic Agent for Diabetes
10/22/2009US20090264500 3-substituted-1,5-diarly-2-alkyl-pyrroles highly selective and orally effective cox-2 inhibitors
10/22/2009US20090264499 Cathepsin C Inhibitors
10/22/2009US20090264498 Cathepsin C Inhibitors
10/22/2009US20090264431 Novel cathepsin c inhibitors and their use
10/22/2009US20090263407 Cationic Lipids and Uses Thereof
10/22/2009US20090263353 Novel Sulphonylpyrroles as Inhibitors of Hdac S Novel Sulphonylpyrroles
10/22/2009US20090263341 Soft anticholinergic esters
10/22/2009CA2719373A1 Processes useful for the synthesis of (r)-1-{2-[4'-(3-methoxypropane-1-sulfonyl)-biphenyl-4-yl]-ethyl}-2-methyl-pyrrolidine
10/21/2009EP2110372A1 Intermediates for the preparation of Pregabalin and process for their preparation
10/21/2009EP2109602A2 Tetracycline derivatives for the treatment of bacterial, viral and parasitic infections
10/21/2009EP2109601A2 Preparation of darifenacin and its salts
10/21/2009EP1608374B9 2-phenoxy- and 2-phenylsulfomamide derivatives with ccr3 antagonistic activity for the treatment of asthma and other inflammatory or immunological disorders
10/21/2009EP1515724B1 Mitotic kinesin inhibitors
10/21/2009CN101563319A Heteroaryl pyrrolidinyl and piperidinyl ketone derivatives
10/21/2009CN101560177A Preparation method of atorvastatin calcium
10/21/2009CN101560176A Amorphous atorvastatin calcium and preparation method thereof
10/21/2009CN100551994C Organic electroluminescent devices and metal complex compounds
10/21/2009CN100551909C Method for producing pyrrolidones
10/21/2009CN100551908C Method for synthesizing cool flavour agent (5-MPC) of derivative of alpha ketone enamine, and application
10/20/2009US7605177 protect neural cells from degeneration and/or death in response to traumatic brain injury or autoimmune disorders of the brain, such as multiple sclerosis and in reducing seizures; hypoxia/ischemia, toxic injury, and chronic neurodegenerative disorders including Parkinson's disease
10/20/2009US7605176 β-ketoamide compounds with MCH antagonistic activity
10/20/2009US7605111 Herbicides
10/20/2009CA2385130C Novel spiroheterocyclic compounds useful as reversible inhibitors of cysteine proteases
10/20/2009CA2380986C Carboxylic acid amides, the preparation thereof and their use as pharmaceutical compositions
10/20/2009CA2358951C Reverse hydroxamate inhibitors of matrix metalloproteinases
10/20/2009CA2336663C Coumarin and related aromatic-based polymeric prodrugs
10/15/2009WO2009126675A1 2-sulfonylamino-4-heteroaryl butyramide antagonists of ccr10
10/15/2009WO2009125861A1 Cysteine protease inhibitor
10/15/2009WO2009125191A1 Benzene derivatives
10/15/2009WO2009072062A3 Derivatives of dihydroxypyrrolidine as anti- cancer compounds
10/15/2009WO2009066072A3 Inhibitors of 17beta-hydroxysteroid dehydrogenase
10/15/2009WO2009023260A3 An improved process for synthesis of pyrrole derivative, an intermediate for atorvastatin
10/15/2009US20090258918 EP4 receptor agonist, compositions and methods thereof
10/15/2009US20090258912 N-(1-Alkyl-2-Phenylethyl)-Carboxamide Derivatives and Use Thereof as Fungicides
10/15/2009US20090258901 Ligands for monoamine receptors and transporters, and methods of use thereof
1 ... 71 72 73 74 75 76 77 78 79 80 81 82 83 84 85 86 87 88 89 90 91 ... 404